We report on our experience of quality of life (QL) assessment in adjuvant clinical trials of the International Breast Cancer Study Group (IBCSG), with special emphasis on cultural and logistical aspects of international organization that are unique to this group. Data are presented regarding submis
Practical issues in quality of life assessment in multicentre trials conducted by the Swiss Group for Clinical Cancer Research
✍ Scribed by Jürg Bernhard; Heidi Gusset; Christoph Hürny
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 130 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0277-6715
No coin nor oath required. For personal study only.
✦ Synopsis
Quality of life (QOL) assessment has become an integrated part in some advanced disease trials and to a lesser extent in early disease trials conducted by the Swiss Group for Clinical Cancer Research (SAKK). In general, the concept of QOL endpoints and the additional work of collecting these data is well accepted by patients, nurses and physicians. The QOL form submission rates in recently completed trials in advanced disease have improved in response to ongoing staff training and supervision as well as direct and personal interventions in the local centres, with 82-86 per cent before treatment failure, and 59-88 per cent at failure. The main source of missing data are local administrative problems, in particular staff oversights.
📜 SIMILAR VOLUMES
The approach of the National Cancer Institute of Canada Clinical Trials Group to measuring compliance, that is, completion rates, for health-related quality of life questionnaires is presented. Completion rates can be measured at the institutional, patient, questionnaire and item levels for baseline